China Securities Network News On February 15th, Beijing time, HHLR Advisors, the fund manager of Gaochun, who focuses on the secondary market investment, announced the report on US stock positions in the fourth quarter of 2021. According to the report, as of the fourth quarter of 2021, the market value of HHLR U.S. stock positions reached 6.472 billion US dollars, a decrease from the previous period. Specifically, HHLR will increase its holdings of biotechnology and new energy vehicle leaders in the fourth quarter of 2021, and clear out Alibaba ADR, Billie Billie in the Internet.

By the end of the fourth quarter of 2021, HHLR held 76 stocks in the U.S. stock market, among which the top ten awkward stocks included: Baekje Shenzhou, On Angpao, Legend Bio, Saffron, Tianjing Bio, JD.COM, SEA, DoorDash, iQiyi and LI, among which 6 were Chinese stocks. Among HHLR's 76 U.S. stock positions, biotechnology, cloud computing, new energy and other technology-based enterprises accounted for more than 70%. HHLR said that China Stock Exchange, medical and technology stocks are its main investment lines.

Whalewisdom website shows that in the fourth quarter of 2021, HHLR increased its holdings by 8 US stocks, with 3 new ones, covering many leading companies in biotechnology and new energy. Specifically, HHLR increased its holdings in LI and Xpeng Motors in the fourth quarter of 2021, with a substantial increase of 3.92 million shares in LI. LI also entered the top 10 Awkwardness stocks of HHLR for the first time.

During the same period, HHLR reduced its holdings of 7 US stocks and cleared 12 stocks. On the whole, HHLR gradually adjusted the positions of China Stock Exchange in the US stock market, which saw a big increase in the previous share price. In the fourth quarter, HHLR cleared Alibaba ADR and Bi Li, and reduced its holdings of Internet companies such as Pinduoduo and Boss Direct Hire.